1. Appel, N.M., Contrera, J.F. and De Souza, E.B. (1989) Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies. J. Pharmacol. Exp. Ther.249, 928–943.
2. Ballard, P.A., Tetrud, J.W. and Langston, J.W. (1985) Permanent human parkinsonism due to l-methyl-4-phe-nyl-l, 2, 3, 6-tetrahydropyridine (MPTP): seven cases. Neurology,35, 949–956.
3. Barnes, D.M. (1989) Neurotoxicity creates regulatory dilemma. Science243, 29–30.
4. Blomqvist, O., Soderpalm, B. and Engel, J. (1992) Etha-nol-induced locomotor activity: Involvement of central nicotinic acetylcholine receptors? Brain Res. Bull.29, 173–178.
5. Blomqvist, O., Engel, J.A., Nissbrandt, N. and Soderpalm, B. (1993) The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Europ. J. Pharmacol.,249, 207–213.